期刊文献+

薄荷醇酯衍生物对压敏胶分散型贴剂中非甾体抗炎药体外经皮渗透性的影响 被引量:3

Influence of O-Acylmenthol Derivatives on in vitro Permeation of Nonsteroidal Antiinflammatory Drugs in Drug-in-adhesive Patches
原文传递
导出
摘要 制备了含不同非甾体抗炎药(酮洛芬、吲哚美辛和双氯芬酸)及促透剂[月桂氮酮、薄荷醇、庚酸薄荷醇酯(M-HEP)或油酸薄荷醇酯(M-OA)]的压敏胶分散型贴剂。采用双室扩散池,以离体大鼠皮肤为屏障进行体外渗透试验,考察了压敏胶和促透剂的种类对贴剂中药物渗透行为的影响。结果表明,用Duro-TAK 87-4098型压敏胶制备的贴剂中酮洛芬的稳态渗透速率和24 h累积透过量显著高于用其他两种压敏胶(Duro-TAK 87-2677和87-2852)制备的贴剂。各促透剂对酮洛芬促渗透作用依序为:M-HEP>M-OA>薄荷醇>月桂氮酮;对吲哚美辛的促渗透作用依序为:M-HEP>M-OA>月桂氮酮≈薄荷醇;M-OA和月桂氮酮对双氯芬酸有显著的促渗透效果,前者的促渗效果较强,而薄荷醇及M-HEP无促渗透作用。 The drug-in-adhesive patches loaded with ketoprofen, indometacin or diclofenac acid with different penetration enhancers [azone, menthol 2-isopropy-5-methylcyclohexyl heptanoate (M-HEP) or (E)-2-isopropyl-5- methylcyclohexyl octadec-9-enoate (M-OA) were prepared, respectively. The in vitro permeability test was carried out with two-chamber cell and excised rat skin to investigate the effects of the types of pressure sensitive adhesive (PSA) and penetration enhancer on permeation behavior of drug in patches. The results showed that the steady state permeation rate and cumulative amount at 24 h of ketoprofen in patches with Duro-TAK 87-4098 PSA were significantly higher than those of other patches with Duro-TAK 87-2677 or 87-2852 PSA. The effects of different penetration enhancers on ketoprofen were in the following order of M-HEP〉M-OA〉menthol〉azone and on indometacin were M-HEP〉M-OA〉azoneg menthol. M-OA and azone had significant effect on diclofenac acid (the former had a stronger effect), while menthol and M-HEP had no enhancing effect.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第8期678-681,共4页 Chinese Journal of Pharmaceuticals
关键词 薄荷醇酯衍生物 非甾体抗炎药 压敏胶分散型贴剂 促透剂 O-acylmenthol derivative nonsteroidal antiinflammatory drugs (NSAIDs) drug-in-adhesive patch penetration enhancer
  • 相关文献

参考文献14

二级参考文献30

共引文献30

同被引文献21

  • 1Zhao L,Fang L,Xu Y,et al.Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers[J].Eur J Pharm Biopharm,2008,69(1):199-213.
  • 2Zhao L,Fang L,Xu Y,et al.Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity[J].Int J Pharm,2008,352(1-2):92-103.
  • 3Samii A, Nutt JG, Ransom BR. Parkinson's disease [J]. Lancet, 2004, 363 (9423) : 1783-1793.
  • 4Zareba G. Rotigotine: a novel dopamine agonist for the trans- dermal treatment of Parkinson's disease [J]. Drugs Today (Barc), 2006, 42 (1) : 21-28.
  • 5Braun M, Elshoff JP, Andreas JO, et al. Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive [J]. Br J Clin Pharmacol, 2009, 68 (3) : 386-394.
  • 6Zhao L, Fang L, Xu Y, et al. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers [ J]. Eur J Pharm Biopharm, 2008, 69 (1) : 199-213.
  • 7Zhao L, Fang L, Xu Y, et al. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity [J]. Int JPharm, 2008, 352 (1-2) : 92-103.
  • 8王刚,杜洪光,张恩宏,许丽丽,王桂蕾,王树明.促渗剂对司来吉兰贴片透皮性能的影响[J].中国药房,2008,19(7):511-513. 被引量:8
  • 9张晓,杜洪光,王树明,陆玉成,高文倩.离子导入对罗替戈汀体外渗透速率的影响[J].中国药学杂志,2009,44(16):1241-1245. 被引量:3
  • 10王刚,申明乐,李建成,万成堂,刘万锋,陈剑兵.司来吉兰贴片处方的正交设计实验研究[J].中国医科大学学报,2010,39(9):746-748. 被引量:3

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部